| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 22 | 2021 | 1067 | 1.220 |
Why?
|
| Ultrasonography, Prenatal | 21 | 2022 | 972 | 0.970 |
Why?
|
| Hypoplastic Left Heart Syndrome | 6 | 2021 | 257 | 0.730 |
Why?
|
| Fetal Heart | 10 | 2017 | 120 | 0.650 |
Why?
|
| Heart Ventricles | 15 | 2021 | 783 | 0.640 |
Why?
|
| Ventricular Function, Left | 10 | 2021 | 514 | 0.640 |
Why?
|
| Heart Defects, Congenital | 17 | 2016 | 1833 | 0.610 |
Why?
|
| Fetal Diseases | 10 | 2017 | 457 | 0.600 |
Why?
|
| Heart Neoplasms | 4 | 2017 | 103 | 0.560 |
Why?
|
| Cardiac Output | 2 | 2016 | 170 | 0.510 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 5 | 2021 | 399 | 0.500 |
Why?
|
| Laser Coagulation | 1 | 2016 | 129 | 0.480 |
Why?
|
| Pregnancy | 37 | 2022 | 7221 | 0.460 |
Why?
|
| Fetofetal Transfusion | 1 | 2016 | 194 | 0.430 |
Why?
|
| Postoperative Complications | 5 | 2017 | 3050 | 0.400 |
Why?
|
| Hydrops Fetalis | 10 | 2022 | 74 | 0.390 |
Why?
|
| Pregnancy Outcome | 10 | 2018 | 596 | 0.370 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2012 | 74 | 0.370 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 99 | 0.360 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2005 | 248 | 0.360 |
Why?
|
| Prenatal Diagnosis | 10 | 2019 | 602 | 0.350 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2021 | 374 | 0.350 |
Why?
|
| Hypertension, Pulmonary | 3 | 2021 | 439 | 0.340 |
Why?
|
| Stroke Volume | 11 | 2016 | 496 | 0.310 |
Why?
|
| Echocardiography, Doppler | 8 | 2011 | 171 | 0.290 |
Why?
|
| Mitral Valve | 4 | 2016 | 252 | 0.290 |
Why?
|
| Fetus | 6 | 2021 | 586 | 0.290 |
Why?
|
| Fetoscopy | 4 | 2021 | 447 | 0.280 |
Why?
|
| Myocardial Contraction | 7 | 2016 | 265 | 0.270 |
Why?
|
| Infant, Newborn | 28 | 2019 | 8275 | 0.260 |
Why?
|
| Teratoma | 3 | 2017 | 126 | 0.250 |
Why?
|
| Gestational Age | 12 | 2019 | 1169 | 0.240 |
Why?
|
| Ventricular Function | 6 | 2016 | 91 | 0.240 |
Why?
|
| Retrospective Studies | 28 | 2021 | 16350 | 0.240 |
Why?
|
| Female | 61 | 2022 | 66719 | 0.230 |
Why?
|
| Ventricular Function, Right | 3 | 2021 | 113 | 0.220 |
Why?
|
| Spinal Dysraphism | 2 | 2019 | 270 | 0.220 |
Why?
|
| Humans | 73 | 2022 | 125138 | 0.220 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 933 | 0.210 |
Why?
|
| Pneumopericardium | 1 | 2003 | 3 | 0.210 |
Why?
|
| Transposition of Great Vessels | 1 | 2004 | 132 | 0.200 |
Why?
|
| Texas | 9 | 2019 | 3572 | 0.200 |
Why?
|
| Mediastinal Emphysema | 1 | 2003 | 11 | 0.200 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 147 | 0.200 |
Why?
|
| Pericardium | 3 | 2017 | 82 | 0.200 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2016 | 112 | 0.200 |
Why?
|
| Thoracic Injuries | 1 | 2003 | 89 | 0.200 |
Why?
|
| Placenta Diseases | 1 | 2022 | 59 | 0.190 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 62 | 0.190 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 1316 | 0.190 |
Why?
|
| Trachea | 2 | 2021 | 203 | 0.180 |
Why?
|
| Hemangioma | 1 | 2022 | 94 | 0.180 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 2 | 2012 | 20 | 0.180 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 211 | 0.180 |
Why?
|
| Aorta | 1 | 2004 | 545 | 0.170 |
Why?
|
| Mitral Valve Stenosis | 2 | 2018 | 36 | 0.170 |
Why?
|
| Infant | 20 | 2021 | 12611 | 0.160 |
Why?
|
| Treatment Outcome | 12 | 2019 | 12276 | 0.160 |
Why?
|
| Thulium | 1 | 2019 | 6 | 0.160 |
Why?
|
| Vascular Resistance | 3 | 2018 | 188 | 0.150 |
Why?
|
| Echocardiography, Three-Dimensional | 3 | 2008 | 53 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 338 | 0.150 |
Why?
|
| Tachycardia, Supraventricular | 3 | 2012 | 109 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2004 | 1123 | 0.140 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 118 | 0.140 |
Why?
|
| Male | 34 | 2019 | 61465 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 189 | 0.140 |
Why?
|
| Insufflation | 1 | 2017 | 20 | 0.140 |
Why?
|
| Child | 24 | 2021 | 24620 | 0.140 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2017 | 43 | 0.140 |
Why?
|
| Blood Flow Velocity | 4 | 2007 | 454 | 0.130 |
Why?
|
| Fetal Therapies | 3 | 2014 | 80 | 0.130 |
Why?
|
| Hernia, Umbilical | 2 | 2015 | 42 | 0.130 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 35 | 0.130 |
Why?
|
| Perinatal Mortality | 1 | 2016 | 43 | 0.130 |
Why?
|
| Twins | 1 | 2016 | 69 | 0.130 |
Why?
|
| Carbon Dioxide | 2 | 2017 | 279 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2008 | 157 | 0.130 |
Why?
|
| Aortic Valve | 2 | 2016 | 444 | 0.130 |
Why?
|
| Adolescent | 21 | 2016 | 19424 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 32 | 0.130 |
Why?
|
| Umbilical Veins | 1 | 2016 | 71 | 0.130 |
Why?
|
| Meningomyelocele | 1 | 2019 | 250 | 0.120 |
Why?
|
| Survival Rate | 3 | 2016 | 2051 | 0.120 |
Why?
|
| Follow-Up Studies | 9 | 2016 | 5169 | 0.120 |
Why?
|
| Stents | 2 | 2019 | 835 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2019 | 543 | 0.120 |
Why?
|
| Pentalogy of Cantrell | 1 | 2015 | 3 | 0.120 |
Why?
|
| Adult | 23 | 2019 | 29470 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 462 | 0.120 |
Why?
|
| Oxygen | 1 | 2018 | 556 | 0.120 |
Why?
|
| Reproducibility of Results | 9 | 2016 | 2878 | 0.120 |
Why?
|
| Vascular Malformations | 1 | 2016 | 90 | 0.120 |
Why?
|
| Hysterotomy | 2 | 2017 | 126 | 0.120 |
Why?
|
| Risk Factors | 7 | 2017 | 10284 | 0.110 |
Why?
|
| Hyperoxia | 1 | 2016 | 129 | 0.110 |
Why?
|
| Heart | 5 | 2004 | 731 | 0.110 |
Why?
|
| Hydrothorax | 1 | 2014 | 11 | 0.110 |
Why?
|
| Ebstein Anomaly | 1 | 2014 | 27 | 0.110 |
Why?
|
| Cardiac Tamponade | 1 | 2014 | 36 | 0.110 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 2907 | 0.110 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 2182 | 0.100 |
Why?
|
| Mediastinal Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Respiratory System Abnormalities | 1 | 2013 | 42 | 0.100 |
Why?
|
| Cesarean Section | 2 | 2013 | 390 | 0.100 |
Why?
|
| Electroencephalography | 1 | 2016 | 869 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 2012 | 33 | 0.090 |
Why?
|
| Cholecystectomy | 1 | 2012 | 58 | 0.090 |
Why?
|
| Adrenalectomy | 1 | 2012 | 38 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 31 | 0.090 |
Why?
|
| Systole | 2 | 2016 | 200 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 515 | 0.090 |
Why?
|
| Leydig Cell Tumor | 1 | 2011 | 7 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 500 | 0.090 |
Why?
|
| Lymphangioma, Cystic | 1 | 2011 | 16 | 0.090 |
Why?
|
| Pneumonectomy | 1 | 2013 | 144 | 0.090 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2012 | 66 | 0.090 |
Why?
|
| Intraoperative Period | 2 | 2005 | 73 | 0.090 |
Why?
|
| Heart Atria | 4 | 2019 | 321 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 2056 | 0.090 |
Why?
|
| Airway Management | 1 | 2011 | 62 | 0.090 |
Why?
|
| Ultrasonography | 5 | 2012 | 939 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2008 | 110 | 0.090 |
Why?
|
| Infant Welfare | 3 | 2004 | 28 | 0.080 |
Why?
|
| Pericardial Effusion | 2 | 2005 | 62 | 0.080 |
Why?
|
| Airway Obstruction | 1 | 2011 | 165 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2013 | 385 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1694 | 0.080 |
Why?
|
| Child, Preschool | 13 | 2016 | 14155 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2016 | 6124 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1319 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 287 | 0.070 |
Why?
|
| Reoperation | 2 | 2016 | 830 | 0.070 |
Why?
|
| Heart Septum | 3 | 2008 | 54 | 0.070 |
Why?
|
| Anthracyclines | 1 | 2007 | 37 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 3606 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 2004 | 256 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 2 | 2019 | 193 | 0.070 |
Why?
|
| Myofibrils | 1 | 2006 | 27 | 0.060 |
Why?
|
| Fetal Death | 3 | 2005 | 112 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 503 | 0.060 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2008 | 143 | 0.060 |
Why?
|
| Drainage | 2 | 2018 | 260 | 0.060 |
Why?
|
| Aortic Coarctation | 2 | 2016 | 110 | 0.060 |
Why?
|
| Cause of Death | 1 | 2008 | 474 | 0.060 |
Why?
|
| Prognosis | 6 | 2016 | 4685 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 225 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3176 | 0.060 |
Why?
|
| Albumins | 1 | 2005 | 93 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2005 | 55 | 0.060 |
Why?
|
| Contraindications | 1 | 2005 | 78 | 0.060 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 22 | 0.060 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 290 | 0.060 |
Why?
|
| Organ Size | 4 | 2017 | 442 | 0.060 |
Why?
|
| Diseases in Twins | 2 | 2017 | 94 | 0.060 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2005 | 87 | 0.060 |
Why?
|
| Infant, Premature | 2 | 2008 | 833 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 165 | 0.050 |
Why?
|
| ROC Curve | 2 | 2016 | 571 | 0.050 |
Why?
|
| Endocarditis | 1 | 2005 | 105 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2004 | 133 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 1395 | 0.050 |
Why?
|
| Prenatal Care | 2 | 2019 | 348 | 0.050 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 92 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 549 | 0.050 |
Why?
|
| Sinus of Valsalva | 1 | 2003 | 35 | 0.050 |
Why?
|
| Football | 1 | 2003 | 31 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2006 | 331 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 777 | 0.050 |
Why?
|
| Heart Aneurysm | 1 | 2002 | 37 | 0.050 |
Why?
|
| Cardiac Catheterization | 2 | 2005 | 632 | 0.050 |
Why?
|
| Bundle-Branch Block | 1 | 2002 | 35 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2007 | 529 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2016 | 4824 | 0.050 |
Why?
|
| Reference Standards | 2 | 2016 | 235 | 0.050 |
Why?
|
| Reference Values | 3 | 2016 | 719 | 0.050 |
Why?
|
| Aortic Rupture | 1 | 2003 | 118 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2003 | 135 | 0.050 |
Why?
|
| Rhabdomyoma | 1 | 2001 | 16 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2005 | 283 | 0.050 |
Why?
|
| Contrast Media | 1 | 2005 | 480 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2016 | 168 | 0.050 |
Why?
|
| Maternal Age | 1 | 2001 | 134 | 0.040 |
Why?
|
| Umbilical Arteries | 2 | 2018 | 98 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 1654 | 0.040 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2014 | 98 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2019 | 618 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2004 | 437 | 0.040 |
Why?
|
| Radiography | 1 | 2003 | 804 | 0.040 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2004 | 282 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 774 | 0.040 |
Why?
|
| Placenta | 2 | 2022 | 508 | 0.040 |
Why?
|
| Coronary Thrombosis | 1 | 2000 | 35 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2005 | 495 | 0.040 |
Why?
|
| Lung Volume Measurements | 1 | 2019 | 75 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2000 | 75 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2018 | 81 | 0.040 |
Why?
|
| Abnormalities, Multiple | 2 | 2016 | 960 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 51 | 0.040 |
Why?
|
| Cardiology | 1 | 2005 | 507 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2016 | 1496 | 0.040 |
Why?
|
| Heart Rate | 6 | 2005 | 582 | 0.040 |
Why?
|
| Genome, Viral | 1 | 1999 | 165 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 117 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 57 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2000 | 243 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 127 | 0.040 |
Why?
|
| Observer Variation | 3 | 2005 | 300 | 0.040 |
Why?
|
| HIV Infections | 2 | 2000 | 1896 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2005 | 996 | 0.040 |
Why?
|
| Exercise | 2 | 1994 | 814 | 0.040 |
Why?
|
| MEDLINE | 1 | 2017 | 20 | 0.040 |
Why?
|
| Norwood Procedures | 1 | 2019 | 101 | 0.040 |
Why?
|
| Endoscopy | 1 | 2019 | 281 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1998 | 104 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2013 | 3424 | 0.030 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1997 | 27 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 440 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 263 | 0.030 |
Why?
|
| Rh Isoimmunization | 1 | 1997 | 28 | 0.030 |
Why?
|
| Torsion, Mechanical | 1 | 2016 | 4 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 162 | 0.030 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1997 | 37 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 68 | 0.030 |
Why?
|
| Time | 1 | 2016 | 91 | 0.030 |
Why?
|
| Georgia | 1 | 2016 | 30 | 0.030 |
Why?
|
| Aging | 3 | 2016 | 1181 | 0.030 |
Why?
|
| Electrocardiography | 3 | 2007 | 976 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2016 | 40 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 28 | 0.030 |
Why?
|
| Time Factors | 3 | 2016 | 6302 | 0.030 |
Why?
|
| Blood Pressure | 4 | 1997 | 1351 | 0.030 |
Why?
|
| HIV-1 | 1 | 1999 | 464 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 257 | 0.030 |
Why?
|
| Young Adult | 3 | 2016 | 9060 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2016 | 143 | 0.030 |
Why?
|
| Sternum | 1 | 2015 | 53 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 1592 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 861 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 681 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 302 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 586 | 0.030 |
Why?
|
| Myocardium | 3 | 2016 | 1022 | 0.030 |
Why?
|
| Tetralogy of Fallot | 1 | 1995 | 164 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1119 | 0.030 |
Why?
|
| Adenoviridae Infections | 1 | 1994 | 71 | 0.030 |
Why?
|
| Blood Volume | 1 | 1994 | 81 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1491 | 0.030 |
Why?
|
| Physical Fitness | 1 | 1993 | 90 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1086 | 0.030 |
Why?
|
| Hypoxia | 2 | 1985 | 249 | 0.030 |
Why?
|
| Respiration | 1 | 1993 | 122 | 0.030 |
Why?
|
| Myocarditis | 1 | 1994 | 130 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 1748 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2016 | 845 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1066 | 0.020 |
Why?
|
| Premature Birth | 1 | 2016 | 388 | 0.020 |
Why?
|
| Indomethacin | 1 | 1991 | 84 | 0.020 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2011 | 6 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 2011 | 13 | 0.020 |
Why?
|
| Oligohydramnios | 1 | 1991 | 46 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1991 | 92 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 1991 | 85 | 0.020 |
Why?
|
| Hemangioendothelioma | 1 | 2011 | 24 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1991 | 63 | 0.020 |
Why?
|
| Exercise Test | 2 | 2007 | 254 | 0.020 |
Why?
|
| Ductus Arteriosus | 1 | 1991 | 62 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2011 | 120 | 0.020 |
Why?
|
| Flecainide | 1 | 1991 | 23 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2011 | 153 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 153 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 224 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2008 | 3310 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2011 | 144 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2570 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2014 | 368 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2016 | 859 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2012 | 432 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 191 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 389 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 1095 | 0.020 |
Why?
|
| Tracheostomy | 1 | 2011 | 196 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2011 | 253 | 0.020 |
Why?
|
| Abortion, Eugenic | 1 | 2008 | 9 | 0.020 |
Why?
|
| Belgium | 1 | 2008 | 43 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 133 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 318 | 0.020 |
Why?
|
| Computer Systems | 1 | 2007 | 37 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2656 | 0.020 |
Why?
|
| Pyridones | 1 | 1988 | 118 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 1999 | 1958 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 3015 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2008 | 173 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 1988 | 139 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2011 | 768 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2007 | 163 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2008 | 353 | 0.020 |
Why?
|
| DNA Primers | 2 | 1999 | 657 | 0.020 |
Why?
|
| Microspheres | 1 | 2005 | 70 | 0.020 |
Why?
|
| Age Factors | 2 | 2004 | 2815 | 0.010 |
Why?
|
| Elasticity | 1 | 2005 | 92 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 248 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 1985 | 100 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 760 | 0.010 |
Why?
|
| Oxygen Consumption | 3 | 1993 | 306 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 305 | 0.010 |
Why?
|
| Aldosterone | 1 | 1984 | 57 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 418 | 0.010 |
Why?
|
| Body Surface Area | 1 | 2004 | 31 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 2004 | 61 | 0.010 |
Why?
|
| Child Welfare | 1 | 2004 | 65 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1684 | 0.010 |
Why?
|
| Base Sequence | 2 | 1999 | 3109 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 620 | 0.010 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2001 | 8 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 3898 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 164 | 0.010 |
Why?
|
| Algorithms | 1 | 2007 | 1630 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2000 | 69 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2000 | 30 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2000 | 94 | 0.010 |
Why?
|
| HIV | 1 | 2000 | 181 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2000 | 198 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 2000 | 149 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 3403 | 0.010 |
Why?
|
| Fetal Blood | 2 | 1994 | 175 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1998 | 77 | 0.010 |
Why?
|
| Random Allocation | 1 | 1999 | 438 | 0.010 |
Why?
|
| Kidney | 1 | 1985 | 1360 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1998 | 166 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 155 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1294 | 0.010 |
Why?
|
| Rabbits | 2 | 1988 | 718 | 0.010 |
Why?
|
| Middle Aged | 1 | 1996 | 26688 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1988 | 971 | 0.010 |
Why?
|
| Captopril | 2 | 1985 | 27 | 0.010 |
Why?
|
| Sheep | 2 | 1985 | 220 | 0.010 |
Why?
|
| Parvovirus | 1 | 1994 | 8 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1994 | 21 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1995 | 185 | 0.010 |
Why?
|
| Angiotensin II | 2 | 1985 | 162 | 0.010 |
Why?
|
| Respiratory Dead Space | 1 | 1993 | 4 | 0.010 |
Why?
|
| Aerobiosis | 1 | 1993 | 13 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1994 | 81 | 0.010 |
Why?
|
| Hematocrit | 1 | 1994 | 114 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1993 | 39 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1994 | 124 | 0.010 |
Why?
|
| Enterovirus | 1 | 1994 | 52 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 1762 | 0.010 |
Why?
|
| Levocardia | 1 | 1993 | 3 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1993 | 134 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1994 | 269 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1994 | 478 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1994 | 312 | 0.010 |
Why?
|
| Birth Weight | 1 | 1994 | 346 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1993 | 215 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1994 | 1017 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1991 | 172 | 0.010 |
Why?
|
| United States | 1 | 2005 | 10884 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1998 | 3675 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 1893 | 0.000 |
Why?
|
| Milrinone | 1 | 1988 | 29 | 0.000 |
Why?
|
| Isoproterenol | 1 | 1988 | 104 | 0.000 |
Why?
|
| Renal Circulation | 1 | 1985 | 44 | 0.000 |
Why?
|
| Animals | 4 | 1988 | 34304 | 0.000 |
Why?
|
| Renin | 1 | 1984 | 84 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1984 | 77 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1984 | 217 | 0.000 |
Why?
|
| Potassium | 1 | 1984 | 284 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1986 | 1018 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1984 | 271 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1985 | 510 | 0.000 |
Why?
|